ID   NALM-6/SP-B
AC   CVCL_0U51
DR   cancercelllines; CVCL_0U51
DR   Wikidata; Q54907438
RX   PubMed=22684370;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:90235; Spiruchostatin B (SP-B).
CC   Sequence variation: Gene fusion; HGNC; 50800; DUX4 + HGNC; 5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0092 ! NALM-6
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 15
//
RX   PubMed=22684370; DOI=10.3892/ijo.2012.1507;
RA   Kanno S.-i., Maeda N., Tomizawa A., Yomogida S., Katoh T., Ishikawa M.;
RT   "Characterization of cells resistant to the potent histone deacetylase
RT   inhibitor spiruchostatin B (SP-B) and effect of overexpressed
RT   p21waf1/cip1 on the SP-B resistance or susceptibility of human
RT   leukemia cells.";
RL   Int. J. Oncol. 41:862-868(2012).
//